FindTrial
Sign In

Effect of Erector Spinae block with different drug combinations on development of chronic after breat cancer surgery

Effect of Erector Spinae block with bupivacaine and ketamine versus bupivacaine alone on chronic postoperative pain in patients undergoing modified radical mastectomy: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051170
Enrollment
50
Registered
2023-03-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Erector Spinae block with Bupivacaine: Erector Spinae block will be given at the level of the 4th Thoracic vertebrae. Drug used will be 30 ml 0.25% Bupivacaine alone Control Interventi

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for Modified Radical Mastectomy surgery for Carcinoma Breast belonging to American Society of Anesthesiologists Physical Status Classification I, II and III.

Exclusion criteria

Exclusion criteria: 1. Patients’ refusal 2. BMI 35Kg/m2 and above. 3. Patients with skin infections at the needle puncture site 4. Any bleeding diathesis 5. Allergic to study medications 6. Patients with CAD 7. Patients with pre-existing dementia and seizure disorder

Design outcomes

Primary

MeasureTime frame
Chronic neuropathic pain as assessed by DN2 questionnaire at 3 monthsTimepoint: 3 months from surgery—

Secondary

MeasureTime frame
Chronic Neuropathic pain as assessed by DN2 questionnaire at 6 monthsTimepoint: 6 months from surgery;Relation between Acute postoperative neuropathic pain and development of chronic neuropathic pain at 3 and 6 monthsTimepoint: 3 months and 6 months from surgery—

Countries

India

Contacts

Public ContactDr Akhil Kant Singh

All India Institute of Medical Sciences

dr.akhilsingh@gmail.com9811702808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026